About MTS Medication Technologies
MTS Medication Technologies is a Healthcare company based in St. Petersburg (United States) founded in 1984, and was acquired by Omnicell in May 2012. Developer of automated medication dispensing machine. MTS Medication Technologies has raised $13 million across 1 funding round from investors including Omnicell, Bank of America and Berwind. Its focus areas include HealthTech, Pharmacy IT, Dispensing Management and Drugs Delivery. Its legal entity is MTS MEDICATION TECHNOLOGIES, INC.
Company details
MTS Medication Technologies (acquired by Omnicell) has developed medication adherence packaging systems. The system enables the pharmacies to manage medication dispensing and administration. The company has developed automated packaging machinery and consumables.
- Headquarters St. Petersburg, United States
- Stage Acquired
- SectorsHealthcare
- Website mts-mt.com
- Acquired by Omnicell (May 2012)
- Legal Name Mts Medication Technologies, Inc
Funding Insights of MTS Medication Technologies
MTS Medication Technologies has successfully raised a total of $13M through 1 strategic funding round. The most recent funding activity was a Series B round of $13 million completed in June 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13M
- Total Rounds 1
- Last Round Series B — $13M
- First Round $13M
(Jun 2004)
- Investors Count 2
All 1 funding rounds of MTS Medication Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2004 | $13M | Series B | – | – |
4 investors in total: 4 institutional.
Investors in MTS Medication Technologies
MTS Medication Technologies has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Omnicell, Bank of America and Berwind.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Berwind is operated as a family-owned investment management company. | berwind.com | Philadelphia, USA | ||
Excellere Partners is engaged in private equity investments. | excellerepartners.com | Denver, USA | ||
Commercial banking and asset management services are offered worldwide. | 1904 | bankofamerica.com | Charlotte, United States | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | omnicell.com | Mountain View, United States |
Investor details for MTS Medication Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MTS Medication Technologies
4 dated milestones of MTS Medication Technologies across 28 years, from founding to its latest funding, stage changes and deals.
- Founded MTS Medication Technologies is founded.
- Funding First funding round of $13.0M.
- Exit Acquired by Excellere Partners.
- Exit Acquired by Omnicell.
Web traffic of MTS Medication Technologies
Websites that share an audience with MTS Medication Technologies (mts-mt.com).
Websites whose visitors overlap most with MTS Medication Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mts-usa.com | 69% | 2.3K | View details |
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as MTS Medication Technologies (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MTS Medication Technologies
MTS Medication Technologies was founded in 1984 and raised its 1st funding round 20 years after it was founded.
MTS Medication Technologies is headquartered in St. Petersburg, United States. It is registered at St. Petersburg, Florida, United States.
MTS Medication Technologies is a funded company, having raised a total of $13M across 1 funding round to date. The company's 1st funding round was a Series B of $13M, raised on Jun 2004.
MTS Medication Technologies (acquired by Omnicell) has developed medication adherence packaging systems. The system enables the pharmacies to manage medication dispensing and administration. The company has developed automated packaging machinery and consumables.
MTS Medication Technologies has 4 investors. Key investors include Omnicell, Bank of America, Berwind, and Excellere Partners.
MTS Medication Technologies operates through Mts Medication Technologies, Inc.
Yes. MTS Medication Technologies was acquired by Omnicell in May 2012.